Welcome to the resource library, where you can find strategy, research and examples of promising practice in medicine, commissioning and drug services for hepatitis C
Resources
Showing 1 to 10 of 173 resources
-
World Hepatitis Day 2018: Global Summary Report
This report, produced by the World Hepatitis Alliance, provides a comprehensive summary of international activity for World Hepatitis Day 2018. 144 countries, 93 governments and 53 WHO Country Offices took part across the six regions. Over 1,600 events were organised, 318,914 people attended events in their local community or country, and millions were reached online.UK, Rest of World 18 Dec 2018 Reports & Research PDF -
HCV Action and Public Health England hepatitis C roadshow in Sheffield: Presentations
On 17th October 2018, HCV Action and Public Health England (PHE) staged a hepatitis C good practice roadshow in Sheffield. The event was designed to showcase and share best practice in the prevention, diagnosis, testing and treatment of hepatitis C, and identify specific issues and potential solutions for tackling hepatitis C in Sheffield and the wider South Yorkshire area.UK, England, Yorkshire and the Humber 12 Nov 2018 Tools & Templates PDF -
Hepatitis B and C epidemiology in selected population groups in the EU/EEA
This report details the findings of a comparative analysis of existing hepatitis B/C testing guidelines and available data on the prevalence and incidence of HBV and HCV among at-risk population groups in EU/EEA countries, to outline the key at-risk groups for hepatitis B and C in EU and EEA countires.UK, Rest of World 30 Oct 2018 Reports & Research PDF -
Addaction Hepatitis C Strategy
Substance misuse service Addaction has produced a Hepatitis C Strategy, detailing the service's five-point plan for contributing to efforts to tackle hepatitis C.UK Strategy & Planning PDF -
Good practice case study: Edinburgh Access Practice outreach service
This HCV Action good practice case study focuses on Edinburgh Access Practice's outreach service, offering testing and treatment for hepatitis C to the homeless population. In the period from March 2014 to December 2016, of the 80 referrals received, 59 patients attended (70%) and 25 started treatment, compared with typical hospital clinical attendance rates of 30-50%. From January 2017 to June 2018 use of DAAs have enabled a further 52 patients to receive treatment at the EAP over the course of just 18 months.UK, Scotland Case study PDF -
Hepatitis C in the UK 2018 Report
Public Health England's annual 'Hepatitis C in the UK' report is the key national reporting document for hepatitis C. This is the tenth such report and follows the WHO Global Health Sector Strategy on Viral Hepatitis 2016 to 2021 and the draft action plan for the health sector response to viral hepatitis in the WHO European region. The report is structured to support UK monitoring of the Global Health Sector Strategy goals and summarises the impact of UK action plans to drive down mortality from HCV and reduce the number of new infections.UK Reports & Research, Strategy & Planning PDF -
R&D, Competition and Diffusion of Innovation in the EU: The Case of Hepatitis C
This research paper assesses the impact of (i) incentives for R&D based on providing Intellectual Property (IP) rights protection, (ii) market competition and (iii) other factors including healthcare policies on access to direct acting antivirals (DAA) for hepatitis C in Europe.UK, Rest of World Reports & Research PDF -
Public health guidance on active case finding of communicable diseases in prison settings
This document, produced by the European Centre for Disease Prevention and Control, provides guidance to EU/EEA member states on prevention and case-finding for communicable diseases, including hepatitis C, in prisons.UK, Rest of World Reports & Research, Strategy & Planning PDF -
In Good Health: A Report following the All Party Pharmacy Group’s 2018 Inquiry into Long Term Conditions
The All Party Pharmacy Group, a parliamentary group, held an inquiry into long term conditions in 2018. The Hepatitis C Trust was invited to give evidence as part of the inquiry and this report, produced following the inquiry, highlights the need to increase testing and treatment for hepatitis C in pharmacies. Pharmacy testing for hepatitis C on the Isle of Wight is also featured as a case study.UK Reports & Research PDF -
Good practice case study: Nottingham University Hospitals NHS Trust Homecare treatment delivery
This HCV Action good practice case study focuses on Nottingham University Hospitals Trust's Homecare treatment delivery project. The project offered patients the option to receive treatment for hepatitis C in their own homes. The project proved popular with patients and resulted in a number of benefits to the service compared with delivering treatment in secondary care.UK, England, East Midlands Case study PDF